The landscape of dementia analysis has advanced radically with the arrival of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent assessments that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. Whilst these technological improvements stand for exceptional development in understanding